• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BJU international >Multiparametric magnetic resonance imaging (MRI) and active surveillance for prostate cancer: future directions
【24h】

Multiparametric magnetic resonance imaging (MRI) and active surveillance for prostate cancer: future directions

机译：前列腺癌的多参数磁共振成像（MRI）和主动监测：未来方向

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

A growing body of data exists suggesting an important role of MRI in selecting men with prostate cancer for active surveillance (AS). In the present study, Park et al. [1] show that a suspicious lesion on MRI was independently predictive of adverse pathology after radical prostatectomy (RP). This finding supports existing data suggesting that suspicious lesions on MRI confer an increased risk of disease reclassincation among men enrolled in AS [2]. Indeed, in our institutional AS experience we found that men with a suspicious lesion on MRI were more likely to have biopsy reclassincation with extended follow-up [3]. While these data are provocative, much work remains to be done before the adoption of MRI as a standard screening tool for entry into AS for men with very low-risk prostate cancer.
机译：越来越多的数据表明MRI在选择前列腺癌男性进行主动监测（AS）中起着重要作用。在本研究中，Park等。 [1]显示，根治性前列腺切除术（RP）后，MRI上的可疑病变可独立预测不良病理。这一发现支持现有的数据，表明MRI上的可疑病变使参加AS的男性中疾病重新分类的风险增加[2]。确实，在我们的机构AS经验中，我们发现MRI上有可疑病变的男性更有可能进行活组织检查重新分类并延长随访时间[3]。尽管这些数据具有启发性，但在将MRI用作极低危前列腺癌男性进入AS的标准筛查工具之前，仍有许多工作要做。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号